EMEA-002760-PIP01-19
Key facts
Invented name |
Rubraca
|
Active substance |
rucaparib camsylate
|
Therapeutic area |
Oncology
|
Decision number |
P/0242/2020
|
PIP number |
EMEA-002760-PIP01-19
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Clovis Oncology Ireland Ltd
E-mail: regulatoryUK@clovisoncology.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|